Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.
School of Medicine, Dentistry & Biomedical Sciences, Queen's University Belfast, Belfast, UK.
Int J Pharm Pract. 2023 May 7;31(3):305-313. doi: 10.1093/ijpp/riad005.
This study aimed to investigate healthcare professionals' barriers to and enablers of deprescribing in older hospice patients at the end of life and prioritise relevant theoretical domains for behaviour change to be incorporated into future interventions to facilitate deprescribing.
Twenty doctors, nurses and pharmacists from four hospices in Northern Ireland participated in qualitative semistructured interviews using Theoretical Domains Framework (TDF)-based topic guides. Data were recorded, transcribed verbatim and analysed inductively using thematic analysis. Deprescribing determinants were mapped to the TDF enabling the prioritisation of domains for behaviour change.
Four prioritised TDF domains represented key barriers to deprescribing implementation; lack of formal documentation of deprescribing outcomes (Behavioural regulation), challenges in communication with patients and families (Skills), lack of implementation of deprescribing tools in practice (Environmental context/resources) and patient and caregiver perceptions of medication (Social influences). Access to information was identified as a key enabler (Environmental context/resources). Perceived risks versus benefits of deprescribing were identified as a key barrier or enabler (Beliefs about consequences).
This study highlights that further guidance on deprescribing in the context of end-of-life is required to address the growing problems of inappropriate prescribing, Guidance should consider factors such as the adoption of deprescribing tools, monitoring and documentation of deprescribing outcomes and how best to discuss prognostic uncertainty.
本研究旨在调查医疗保健专业人员在临终老年临终关怀患者中减少用药的障碍和促进因素,并确定相关的理论领域,以便将其纳入未来的干预措施,以促进减少用药。
来自北爱尔兰四家临终关怀机构的 20 名医生、护士和药剂师参加了基于理论领域框架(TDF)的半结构化访谈,使用 TDF 主题指南。记录、逐字转录数据,并使用主题分析进行归纳分析。将减少用药的决定因素映射到 TDF 上,以便为行为改变确定优先领域。
四个优先 TDF 领域代表了减少用药实施的主要障碍;缺乏减少用药结果的正式记录(行为规范)、与患者和家属沟通的挑战(技能)、减少用药工具在实践中的实施不足(环境背景/资源)以及患者和护理人员对药物的看法(社会影响)。获取信息被认为是一个关键的促进因素(环境背景/资源)。减少用药的感知风险与收益被确定为一个关键的障碍或促进因素(对后果的信念)。
本研究强调,在临终关怀背景下,需要进一步的减少用药指南来解决不适当用药的日益严重问题。指南应考虑采用减少用药工具、监测和记录减少用药的结果,以及如何最好地讨论预后的不确定性等因素。